A phase II/III study of SYR-322 in subject with diabetes
Phase 2
- Conditions
- Diabetes mellitus
- Registration Number
- JPRN-jRCT2080220871
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The subject who is capable of providing consent to participate in this study, with ability to read and understand the informed consent form and other written information, etc.
Exclusion Criteria
1.The subject with serious cardiac disease, cerebrovascular disorder, or serious pancreatic or hematological disease, etc.
2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method